“Takeda Initiates Cardiovascular Outcomes Trial for Alogliptin, An Investigational Treatment for Type 2 Diabetes” (PharmaLive)
“Intelence (etravirine):Reports of severe, potentially life-threatening and fatal skin reactions” (MedWatch)
“Sinovac H1N1 Vaccine Shows Immunogenicity In Trial – Update “ (RTT News)
“P&G’s Outlast Aims to Outfox Private Label” (Brandweek)
“Study could boost new Astra-Zeneca Enhanced Coverage” (MarketWatch)
“Hope Plays Role in Stroke Risk” (MedPage Today)
“ESC: PLATO Results Signal New Era in Treatment of ACS” (MedPage Today)
“Study Shows Otamixaban substantially Reduced Complications of Invasive Management of Acute Coronary Syndromes” (Sanofi-Aventis Press Release)
“Abbott Launches Next-Generation XIENCE PRIME(TM) Drug Eluting Stent in International Markets” (Press release issued by Abbott)
SUBSCRIBE